Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Other Business Activities by Quarter
Other Business Activities (PC1, R&D platforms & corporate research) — Pretax loss ($M) ($M)
Pfizer Other Business Activities: -$1,708M in Q2 2026, down 3.1% from a year earlier.
Latest, Q2 2026
-1,708
Period ended Jun 28, 2026
Change on a year earlier
-3.1%
-1,762 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
29
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Note 17 — Segment Reporting (ASU 2023-07 Significant Segment Expenses).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Business Activities (PC1, R&D platforms & corporate research) — Pretax loss ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | -1,708 | -3.1% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | -1,668 | +20.5% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | -1,969 | +7.9% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 28, 2025 | -3,084 | +108.8% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | -1,762 | -11.2% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2025 | Mar 30, 2025 | -1,384 | -31.0% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | -1,825 | +112.2% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 29, 2024 | -1,477 | +34.3% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | -1,985 | +118.1% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | -2,007 | +52.5% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2023 | Dec 31, 2023 | -860 | -118.5% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2023 | Oct 1, 2023 | -1,100 | -72.5% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2023 | Jul 2, 2023 | -910 | -73.1% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2023 | Apr 2, 2023 | -1,316 | -45.8% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2022 | Dec 31, 2022 | 4,658 | -182.1% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2022 | Oct 2, 2022 | -4,007 | +21.3% | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2022 | Jul 3, 2022 | -3,384 | +34.1% | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2022 | Apr 3, 2022 | -2,429 | +18.6% | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2021 | Dec 31, 2021 | -5,677 | -37.9% | Form 10-K (filed 2024-02-22) ↗ |
| Q3 2021 | Oct 3, 2021 | -3,303 | +177.1% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2021 | Jul 4, 2021 | -2,524 | +122.2% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2021 | Apr 4, 2021 | -2,048 | +84.5% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2020 | Dec 31, 2020 | -9,146 | +28.8% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2020 | Sep 27, 2020 | -1,192 | -17.2% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 28, 2020 | -1,136 | -18.8% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 29, 2020 | -1,110 | -13.1% | Form 10-Q (filed 2020-05-07) ↗ |
| Q4 2019 | Dec 31, 2019 | -7,100 | +289.0% | Form 10-K (filed 2022-02-24) ↗ |
| Q3 2019 | Sep 29, 2019 | -1,439 | -13.2% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | -1,399 | -11.2% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | -1,278 | -3.5% | Form 10-Q (filed 2020-05-07) ↗ |
| Q4 2018 | Dec 31, 2018 | -1,825 | -23.7% | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | -1,658 | +21.6% | Form 10-Q (filed 2019-11-07) ↗ |
| Q2 2018 | Jul 1, 2018 | -1,576 | +30.4% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2018 | Apr 1, 2018 | -1,325 | -0.7% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | -2,391 | – | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2017 | Oct 1, 2017 | -1,363 | – | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2017 | Jul 2, 2017 | -1,209 | – | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2017 | Apr 2, 2017 | -1,335 | – | Form 10-Q (filed 2018-05-10) ↗ |
Cite this data
StockData. (2026). Pfizer Other Business Activities ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/seg-ebt-oba
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.